Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

9(100.0%)

9Total

N/A(9)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07209020Not ApplicableRecruiting

HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery

Role: lead

NCT06994546Not ApplicableRecruiting

ArtiBest for Knee Osteoarthritis

Role: lead

NCT06252935Not ApplicableRecruiting

Effectiveness and Safety of Collagen Membrane (FormaAid®) in the Treatment of Periodontal Regeneration

Role: lead

NCT05935449Not ApplicableCompleted

The Clinical Trial of Difference Between Formaderm Lidocaine and Formaderm Dermal Filler Injection

Role: lead

NCT06280053Not ApplicableCompleted

HealiAid in the Treatment of Different Wounds

Role: lead

NCT05935501Not ApplicableCompleted

Clinical Trial of Cross-linked Hyaluronic Acid Dermal Filler

Role: lead

NCT05881317Not ApplicableCompleted

ArtiAid® Plus for Knee Osteoarthritis: A Post-market Study

Role: lead

NCT05881330Not ApplicableCompleted

ArtiAid® for Knee Osteoarthritis: A Post-market Study

Role: lead

NCT05822778Not ApplicableCompleted

Formaderm (Hyaluronic Acid) for Facial Soft Tissue Augmentation

Role: lead

All 9 trials loaded